Bill Text: TX SB122 | 2025-2026 | 89th Legislature | Introduced

---

Bill Title: Relating to required labeling of certain products containing or derived from aborted human fetal tissue.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2024-11-12 - Filed [SB122 Detail]

Download: Texas-2025-SB122-Introduced.html

---

89R2547 KKR-D
By: Hall S.B. No. 122

A BILL TO BE ENTITLED
AN ACT
relating to required labeling of certain products containing or
derived from aborted human fetal tissue.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Subchapter D, Chapter 431, Health and Safety
Code, is amended by adding Section 431.085 to read as follows:
Sec. 431.085. LABELING REQUIRED FOR FETAL TISSUE FOOD
PRODUCT. (a) In this section:
(1) "Fetal tissue food product" means a food or food
additive that:
(A) contains human fetal tissue;
(B) is manufactured using human fetal tissue; or
(C) is otherwise derived from research using
human fetal tissue.
(2) "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b) A person may not sell in this state a fetal tissue food
product unless the product is clearly and conspicuously labeled in
accordance with department rules.
(c) The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 2. Subchapter E, Chapter 431, Health and Safety
Code, is amended by adding Section 431.118 to read as follows:
Sec. 431.118. LABELING REQUIRED FOR FETAL TISSUE MEDICAL
PRODUCT. (a) In this section:
(1) "Fetal tissue medical product" means a medication,
vaccine, or other medical product used in medical treatment that:
(A) contains human fetal tissue;
(B) is manufactured using human fetal tissue; or
(C) is otherwise derived from research using
human fetal tissue.
(2) "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b) A person may not sell, dispense, or administer in this
state a fetal tissue medical product unless the product is clearly
and conspicuously labeled in accordance with department rules.
(c) The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 3. Subchapter F, Chapter 431, Health and Safety
Code, is amended by adding Section 431.143 to read as follows:
Sec. 431.143. LABELING REQUIRED FOR FETAL TISSUE COSMETIC
PRODUCT. (a) In this section:
(1) "Fetal tissue cosmetic product" means a cosmetic
product that:
(A) contains human fetal tissue;
(B) is manufactured using human fetal tissue; or
(C) is otherwise derived from research using
human fetal tissue.
(2) "Human fetal tissue" means tissue, cells,
including cells from fetal cell lines, or organs obtained or
originally derived from an aborted unborn child.
(b) A person may not sell in this state a fetal tissue
cosmetic product unless the product is clearly and conspicuously
labeled in accordance with department rules.
(c) The executive commissioner by rule shall prescribe the
form and contents of the label required by Subsection (b).
SECTION 4. (a) Not later than December 1, 2025, the
executive commissioner of the Health and Human Services Commission
shall adopt the form and content of the labels required under
Sections 431.085, 431.118, and 431.143, Health and Safety Code, as
added by this Act.
(b) Sections 431.085, 431.118, and 431.143, Health and
Safety Code, as added by this Act, apply only to a fetal tissue
product sold, dispensed, or administered on or after January 1,
2026.
SECTION 5. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2025.